Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Antiviral Research|March 17, 2022
Development of accelerated high-throughput antiviral screening systems for emerging orthomyxovirusesSatoko Yamaoka, Carla M Weisend, Vaille A Swenson, et al.The Journal of General Virology|February 1, 2003
Translational regulation of rotavirus gene expressionDana N Mitzel, Carla M Weisend, Michael W White, et al.Infection Control and Hospital Epidemiology|January 26, 2022
Inactivation of replication-competent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on common surfaces by disinfectantsZachary C Pope, Carla M Weisend, Aditya Shah, et al.Antiviral Research|December 9, 2020
The NF-κB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandavirusesCrystal A Mendoza, Satoko Yamaoka, Yoshimi Tsuda, et al.Genesis (New York, N.Y. : 2000)|October 16, 2009
Cre activity in fetal albCre mouse hepatocytes: Utility for developmental studiesCarla M Weisend, Jean A Kundert, Elena S Suvorova, et al.Journal of Virology|August 21, 2002
Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1Joel W Graff, Dana N Mitzel, Carla M Weisend, et al.Plos One|January 26, 2010
ICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 geneMingyu Liu, Brandon Rakowski, Edward Gershburg, et al.Plos One|July 9, 2009
Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytesElena S Suvorova, Olivier Lucas, Carla M Weisend, et al.Journal of Cell Science|June 24, 2010
Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regenerationMaryClare F Rollins, Dana M van der Heide, Carla M Weisend, et al.Biomolecules|June 2, 2021
Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target EngagementMathew A Coban, Juliet Morrison, Sushila Maharjan, et al.Pageof 1